z-logo
open-access-imgOpen Access
Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies
Author(s) -
George S. Laszlo,
Johnnie J. Orozco,
Allie R. Kehret,
Margaret C. Lunn-Halbert,
Jenny Huo,
Donald K. Hamlin,
D. Scott Wilbur,
Shan L. Dexter,
Melissa L. Comstock,
Shyril O’Steen,
Brenda M. Sandmaier,
Damian J. Green,
Roland B. Walter
Publication year - 2022
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-022-01580-7
Subject(s) - radioimmunotherapy , interleukin 3 receptor , leukemia , cancer research , monoclonal antibody , medicine , stem cell , immunology , biology , antibody , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom